For each of the RNA-seq data sets corresponding to three adenocarcinoma and 3 non-tumour adjacent prostate tissue samples [11], we looked for the presence of a fusion gene, TMPRSS2:ERG, which is known to be common in prostate adenocarcinoma, and is a strong prognostic indicator [12]. This evidence concerns the gene ERG and neoplasm.